Evidence map›Paper›PMID 41156090›Full record

ArticleJournal of clinical medicine2025

Immune Checkpoint-Induced Colitis: A Single-Center Retrospective Cohort Study.

Bengt Van Holder, Julie Vereecke, Nathan Ureel, Triana Lobatón, Anne Hoorens, Amber Lievens, Marie Truyens, Sylvie Rottey, Karim Vermaelen, Venita D'Cruz and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Bengt Van HolderDepartment of Medical Oncology, Ghent University Hospital, 9000 Ghent, Belgium.
Julie VereeckeFaculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.
Nathan UreelFaculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.
Triana LobatónFaculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0003-1817-7704
Anne HoorensFaculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0002-0736-2034
Amber LievensFaculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.
Marie TruyensFaculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.
Sylvie RotteyDepartment of Medical Oncology, Ghent University Hospital, 9000 Ghent, Belgium.
Karim VermaelenFaculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.
Venita D'CruzDepartment of Gastroenterology and Hepatology, Ghent University Hospital, 9000 Ghent, Belgium.
Jeroen GeldofFaculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0003-0126-2929
Celine JacobsDepartment of Medical Oncology, Ghent University Hospital, 9000 Ghent, Belgium.ORCID 0000-0001-5286-3519
Eline NaertDepartment of Medical Oncology, Ghent University Hospital, 9000 Ghent, Belgium.ORCID 0000-0002-1508-7263
Elien De MulderDepartment of Medical Oncology, Ghent University Hospital, 9000 Ghent, Belgium.
Michael SaerensDepartment of Medical Oncology, Ghent University Hospital, 9000 Ghent, Belgium.ORCID 0000-0001-5523-6537

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

colitisimmune-related adverse eventsimmunotherapyinfliximabvedolizumab

Identifiers

PMID41156090
PMCPMC12565555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.